US Patent 7119066 Modified ciliary neurotrophic factor (CNTF)
Patent 7119066 was granted and assigned to Regeneron Pharmaceuticals, Inc. on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+198 characters)
Article
Patent abstract
Modified ciliary neurotrophic factor, methods for production and methods of use, especially in the treatment of Huntington's disease, obesity, and gestational or adult onset diabetes.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07119066 Modified ciliary neurotrophic factor (CNTF) US Patent 7119066 Modified ciliary neurotrophic factor (CNTF)
Infobox
Patent Number
0711906600
Patent Number
711906600
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
071190660
Date of Patent
October 10, 2006
0Patent Application Number
102816430
Date Filed
October 28, 2002
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
071190660
Date of Patent
October 10, 2006
0Patent Application Number
102816430
Date Filed
October 28, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07119066 Modified ciliary neurotrophic factor (CNTF)
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07119066
Date of patent
October 10, 2006
Patent application number
10281643
Date Filed
October 28, 2002
Patent primary examiner
Find more entities like US Patent 7119066 Modified ciliary neurotrophic factor (CNTF)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
